A Comprehensive Investigation of the Potential Role of Lipoproteins and Metabolite Profile as Biomarkers of Alzheimer’s Disease Compared to the Known CSF Biomarkers
Nasab A, Noorani F, Paeizi Z, Khani L, Banaei S, Sadeghi M, Shafeghat M, Shafie M, Mayeli M, Initiative T. A Comprehensive Investigation of the Potential Role of Lipoproteins and Metabolite Profile as Biomarkers of Alzheimer’s Disease Compared to the Known CSF Biomarkers. International Journal Of Alzheimer's Disease 2023, 2023: 3540020. PMID: 36936136, PMCID: PMC10019964, DOI: 10.1155/2023/3540020.Peer-Reviewed Original ResearchAssociated with Alzheimer's diseaseCerebrospinal fluidNegative groupCore biomarkersCerebrospinal fluid core biomarkersP-tauCorrelation of metabolitesMetabolites of patientsGlycolysis-related metabolitesAlzheimer's diseaseSubclasses of lipoproteinsPotential noninvasive markersAssociation of lipoproteinsCerebrospinal fluid tauAlzheimer's Disease Neuroimaging InitiativeFatty acidsNo significant differenceGene statusNoninvasive markerAD core biomarkersAD developmentBiomarkers of Alzheimer's diseasePositive groupSmall HDLAmino acids
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply